ACST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 May 2024 @ 16:00):

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases...

Stats
Today's Volume	11 892.00
Average Volume	26 325.00
Market Cap	27.73M
EPS	$-0.300 ( 2024-02-13 )
Next earnings date	( $-0.350 ) 2024-06-28
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.520
ATR14	$0.0440 (1.49%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-05	Delaversano Robert J	Sell	42 000	Stock Options (Right to Buy)
2023-12-19	Kavuru Vimal	Buy	10 000	Stock Options (Right to Buy)
2023-12-19	Kottayil George	Buy	22 500	Stock Options (Right to Buy)
2023-12-19	Neugeboren Edward	Buy	22 500	Stock Options (Right to Buy)
2023-12-19	Davis A Brian	Buy	22 500	Stock Options (Right to Buy)

INSIDER POWER
88.75
Last 64 transactions
Buy: 4 252 386 \| Sell: 2 858 533

Acasti Pharma Inc Correlation

10 Most Positive Correlations
IKT	0.947
CRDO	0.926
AGFY	0.92
ALRM	0.919
ELTK	0.916
FROG	0.916
TRIP	0.909
KRT	0.906
MRVL	0.906
TRMB	0.905

10 Most Negative Correlations
DCRC	-0.902
SGLB	-0.897
NEXT	-0.895
ECOR	-0.889
HFBL	-0.889
IRTC	-0.887
MTEK	-0.882
HIBB	-0.88
WTFC	-0.876
HALL	-0.876

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Acasti Pharma Inc Financials

Annual	2022
Revenue:	$0
Gross Profit:	$-52.16M (0.00 %)
EPS:	$-5.71

FY	2022
Revenue:	$0
Gross Profit:	$-52.16M (0.00 %)
EPS:	$-5.71

FY	2022
Revenue:	$0
Gross Profit:	$-15.59M (0.00 %)
EPS:	$-0.270

FY	2021
Revenue:	$196 000
Gross Profit:	$120 000 (61.22 %)
EPS:	$-1.360

Financial Reports:

No articles found.

Acasti Pharma Inc

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.